TCN-202 is a broadly protective, fully human monoclonal antibody, being developed for the treatment of human cytomegalovirus infection.
http://eon.businesswire.com/news/eon/20130402005304/en/Theraclone-Sciences-Announces-Positive-Top-line-Data-Phase
http://eon.businesswire.com/news/eon/20130402005304/en/Theraclone-Sciences-Announces-Positive-Top-line-Data-Phase
No comments:
Post a Comment